We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Testicular cancer is the most commonly-found tumour in men aged between 15 and 35. More than 90% of testicular cancers develop in the germ cells, which are responsible for producing sperm.
Secondary testicular tumours are caused by cancer cells that spread to the testicles from other parts of the body (metastasis). These cancers are much less common than the other forms of testicular cancer mentioned above.
While these tumours originate in the testicles, they may also occasionally appear in the abdomen, chest or other parts of the body, either as a primary tumour or as distant involvement of a primary tumour in the testicle.
Testicular cancer usually presents as a unilateral, non-painful testicular mass or as an incidental finding in an ultrasound examination.
The causes of testicular cancer are not known, but there are factors that can increase the risk of this disease, such as:
There is no known connection between testicular cancer and testicular trauma, muscle tears, hot baths or tight-fitting clothing.
Once treatment is completed, vigilance is of vital importance. The doctor will recommend self-examinations and regular check-ups.
During check-ups, the urologist will examine the unaffected testicle for lumps or abnormalities; perform regular blood tests to quantify tumour markers; and perform imaging tests - such as chest x-rays or regular CT scans - to check for the recurrence of any tumours.
Testicular cancer is a type of cancer that can be effectively treated and potentially cured if it is diagnosed and treated on time. Advanced testicular cancer can also be cured with treatment.
Neither testicular cancer nor the surgical removal of a testicle should impair sexual function or fertility. The surgical removal of a testicle has a minimal impact on a man's fertility, as a single testicle produces large amounts of sperm on its own. For men who require further treatment, fertility may be temporarily affected.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.